RET and multiple endocrine neoplasia type 2A: Due to the founder effect of the C611Y mutation in Denmark, a large proportion of the Danish multiple endocrine neoplasia type 2A (MEN2A) cohort comprise patients with RET mutations classified in the American Thyroid Association moderate risk level (7,39,40).